Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
Status:
Completed
Trial end date:
2020-07-23
Target enrollment:
Participant gender:
Summary
Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2,
highlighting urgency around identifying effective therapies.
This study aiming to evaluate the anti-HCV medications efficacy "Sofosbuvir-Ledipasvir" in
treatment of moderate cases with SARS-COV-2 infection, in comparison to the standard
treatment (hydroxychloroquine, oseltamivir and azithromycin).